Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Chem ; 39(4): 345-57, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15072843

ABSTRACT

NF449 [4,4',4",4"'-(carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid-octasodiumsalt)] was recently described to inhibit recombinant rP2X(1) receptors (Naunyn Schmiedeberg's Arch. Pharmacol. 364 (2001) 285). The purpose of this study was to examine structure-activity-relationships at P2 receptors of a series of NF449 analogues. Thus, compounds containing various arylaminemono-, di-, or trisulfonic acids and a replacement of the central urea bridge were synthesized. NF449 displayed a pIC(50) at P2X(1) receptors (rat vas deferens) of 6.31 +/- 0.04 being at least 19-fold more potent at P2X(1) than at P2X(3), P2Y(1), P2Y(2), or P2Y(11). Any deletion or change of position of sulfonic acid groups or replacing the central urea bond by the bisamide of terephthalic acid reduced the potency at P2X(1) by at least 90%. All compounds were very weak antagonists at P2Y(2) or P2Y(11) receptors (pIC(50) < 4.5). In conclusion, NF449 remains the most potent and selective P2X(1) antagonist known. Potential lead compounds among the suramin class for P2X(3) (16d) and P2Y(1) (16a) receptors were identified.


Subject(s)
Benzenesulfonates/pharmacology , Purinergic P2 Receptor Antagonists , Adenosine Triphosphate/metabolism , Animals , Benzenesulfonates/chemistry , Cell Line , Dose-Response Relationship, Drug , Guinea Pigs , Humans , Ileum/drug effects , Ileum/metabolism , Lethal Dose 50 , Male , Rats , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X , Structure-Activity Relationship , Suramin/analogs & derivatives , Suramin/pharmacology , Uridine Triphosphate/metabolism , Vas Deferens/drug effects , Vas Deferens/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...